For the year ending 2025-12-31, HSTM had -$23,308K decrease in cash & cash equivalents over the period. $59,634K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 18,342 |
| Depreciation and amortization | 43,478 |
| Stock-based compensation | 8,145 |
| Amortization of deferred commissions | 12,633 |
| Provision for credit losses | 1,008 |
| Deferred income taxes | 5,117 |
| Loss on equity method investments | -190 |
| Change in fair value of non-marketable equity investments | 0 |
| Other | 1,315 |
| Accounts and unbilled receivables | 3,983 |
| Prepaid royalties | -1,910 |
| Other prepaid expenses and other current assets | 2,873 |
| Other assets | 19,266 |
| Accounts payable and accrued expenses | 1,421 |
| Accrued royalties | 405 |
| Deferred revenue | -1,893 |
| Net cash provided by operating activities | 63,319 |
| Cash paid for acquisitions, net of cash acquired | 35,091 |
| Proceeds from maturities of marketable securities | 52,086 |
| Proceeds from sale of marketable securities | 9,770 |
| Purchases of marketable securities | 43,496 |
| Proceeds from sale of fixed assets | 41 |
| Purchase of other investments | 1,500 |
| Proceeds from sale of non-marketable equity investments | 0 |
| Payments associated with capitalized software development | 28,478 |
| Purchases of property and equipment | 3,685 |
| Net cash used in investing activities | -50,353 |
| Taxes paid related to net settlement of equity awards | 2,516 |
| Payment of debt issuance costs | 0 |
| Repurchases of common stock | 30,022 |
| Payment of cash dividends | 3,729 |
| Net cash used in financing activities | -36,267 |
| Effect of exchange rate changes on cash and cash equivalents | -7 |
| Net (decrease) increase in cash and cash equivalents | -23,308 |
| Cash and cash equivalents at beginning of period | 59,469 |
| Cash and cash equivalents at end of period | 36,161 |
HEALTHSTREAM INC (HSTM)
HEALTHSTREAM INC (HSTM)